Metronidazole exposure-response and safety in infants.

Saved in:
Bibliographic Details
Title: Metronidazole exposure-response and safety in infants.
Authors: Randell RL; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Balevic SJ; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Greenberg RG; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Cohen-Wolkowiez M; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Smith MJ; Department of Pediatrics, Duke University, Durham, North Carolina, USA., Benjamin DK Jr; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Bendel C; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Bliss JM; Department of Pediatrics, Division of Neonatology, University of Rochester Medical Center, Rochester, New York, USA., Chaaban H; Department of Pediatrics, Division of Neonatology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA., Chhabra R; Department of Pediatrics, Division of Neonatology, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA., Dammann CEL; Department of Pediatrics, Tufts Medical Center, Tufts University, Boston, Massachusetts, USA., Downey LC; Department of Pediatrics, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA., Hornik CD; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Hussain N; Department of Pediatrics, Division of Neonatology, Connecticut Children's, Hartford, Connecticut, USA., Laughon MM; Department of Pediatrics, Division of Neonatal-Perinatal Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lavery A; Children's Hospital of Orange County, Orange, California, USA., Moya F; Pediatrix Medical Group, Austin, Texas, USA., Saxonhouse M; Department of Pediatrics, Division of Neonatology, Levine Children's Hospital, Wake Forest School of Medicine Charlotte Campus, Atrium Healthcare, Charlotte, North Carolina, USA., Sokol GM; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA., Trembath A; Division of Neonatal-Perinatal Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Weitkamp J-H; Mildred Stahlman Division of Neonatology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hornik CP; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA.
Corporate Authors: Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Nov 05; Vol. 69 (11), pp. e0037725. Date of Electronic Publication: 2025 Sep 19.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00377-25